ATE223722T1 - Verfahren zur herstellung von efonidipinhaltigen arzneimitteln - Google Patents

Verfahren zur herstellung von efonidipinhaltigen arzneimitteln

Info

Publication number
ATE223722T1
ATE223722T1 AT97907336T AT97907336T ATE223722T1 AT E223722 T1 ATE223722 T1 AT E223722T1 AT 97907336 T AT97907336 T AT 97907336T AT 97907336 T AT97907336 T AT 97907336T AT E223722 T1 ATE223722 T1 AT E223722T1
Authority
AT
Austria
Prior art keywords
treatment
mixture
water
efonidipine
efonidipine hydrochloride
Prior art date
Application number
AT97907336T
Other languages
English (en)
Inventor
Misao Miyamoto
Toshihisa Oda
Toyohiko Bunrin
Toshio Okabe
Tetsuyuki Nishiyama
Original Assignee
Nissan Chemical Ind Ltd
Zeria Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd, Zeria Pharm Co Ltd filed Critical Nissan Chemical Ind Ltd
Application granted granted Critical
Publication of ATE223722T1 publication Critical patent/ATE223722T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97907336T 1996-03-18 1997-03-17 Verfahren zur herstellung von efonidipinhaltigen arzneimitteln ATE223722T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8886896 1996-03-18
JP8886996 1996-03-18
PCT/JP1997/000842 WO1997034610A1 (en) 1996-03-18 1997-03-17 Process for producing efonidipine hydrochloride preparations

Publications (1)

Publication Number Publication Date
ATE223722T1 true ATE223722T1 (de) 2002-09-15

Family

ID=26430207

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97907336T ATE223722T1 (de) 1996-03-18 1997-03-17 Verfahren zur herstellung von efonidipinhaltigen arzneimitteln

Country Status (11)

Country Link
US (1) US6171599B1 (de)
EP (1) EP0893999B8 (de)
KR (1) KR100457273B1 (de)
AT (1) ATE223722T1 (de)
AU (1) AU1941897A (de)
CA (1) CA2248582C (de)
DE (1) DE69715395T2 (de)
ES (1) ES2184063T3 (de)
PT (1) PT893999E (de)
TW (1) TW487574B (de)
WO (1) WO1997034610A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2287971T3 (es) 1997-08-11 2007-12-16 Pfizer Products Inc. Dispersiones farmaceuticas solidas con biodisponibilidad incrementada.
EP1479666A4 (de) * 2002-02-28 2010-10-13 Japan Tobacco Inc Esterverbindung und deren medizinische verwendung
JP4832897B2 (ja) * 2003-08-29 2011-12-07 日本たばこ産業株式会社 エステル誘導体及びその医薬用途
US20060030623A1 (en) * 2004-07-16 2006-02-09 Noboru Furukawa Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
US20080095841A1 (en) * 2004-10-06 2008-04-24 Eisai R&D Management Co., Ltd. Pharmaceutical Composition, Method for Producing the Same, and Method for Stabilizing Dihydropyridine Compound in the Pharmaceutical Composition
US8101774B2 (en) * 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof
KR20070072888A (ko) * 2004-10-25 2007-07-06 니뽄 다바코 산교 가부시키가이샤 용해성 및 안정성이 개선된 고형 제제 및 그의 제조 방법
WO2006118210A1 (ja) * 2005-04-28 2006-11-09 Eisai R & D Management Co., Ltd. ジヒドロピリジン系化合物の分解を防止する方法
WO2007108463A1 (ja) 2006-03-23 2007-09-27 Shionogi & Co., Ltd. 溶解性が改善された固形製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1016063B (zh) * 1986-01-22 1992-04-01 日产化学工业株式会社 二氢吡啶-5-膦酸环亚丙基酯的制备
JP2528706B2 (ja) 1988-05-30 1996-08-28 ゼリア新薬工業株式会社 ジヒドロピリジン化合物の製剤組成物

Also Published As

Publication number Publication date
KR20000064632A (ko) 2000-11-06
CA2248582C (en) 2005-06-14
EP0893999B8 (de) 2003-01-02
DE69715395T2 (de) 2003-05-15
ES2184063T3 (es) 2003-04-01
KR100457273B1 (ko) 2005-04-08
US6171599B1 (en) 2001-01-09
TW487574B (en) 2002-05-21
WO1997034610A1 (en) 1997-09-25
CA2248582A1 (en) 1997-09-25
EP0893999A1 (de) 1999-02-03
DE69715395D1 (de) 2002-10-17
AU1941897A (en) 1997-10-10
PT893999E (pt) 2002-12-31
EP0893999B1 (de) 2002-09-11

Similar Documents

Publication Publication Date Title
ATE170876T1 (de) Bilden von lösungen von cellulose in wässrigem tertiärem aminoxid
DE69718942D1 (de) Verfahren zur herstellung von erythromicin a-oxim
ATE223722T1 (de) Verfahren zur herstellung von efonidipinhaltigen arzneimitteln
DE3773210D1 (de) Verfahren zur herstellung eines aktivkohlekatalysators.
SU604462A3 (ru) Способ стерилизации упаковочного материала
KR870007661A (ko) α화 건조미의 제조방법
FI971932A0 (fi) Menetelmä pesu- ja puhdistusainetablettien valmistamiseksi mikroaalto- ja kuumailmakäsittelyllä
JPS51142482A (en) A process and apparatus for treatment of putrefactive wastes
ATE371675T1 (de) Verfahren zur herstellung von xylooligosacchariden
DE69100063D1 (de) Verfahren zur herstellung von getrockneten teigwaren.
MY110907A (en) Method and apparatus for treating wood material and porous inorganic material
KR0128105B1 (ko) 홍삼제조방법
ATE246982T1 (de) Vorrichtung und verfahren zum behandeln von kunststoffmaterial
JPS5515622A (en) Exhaust gas pretreating method
JPS5424457A (en) Process for swelling treatment of organic sludge
HU904060D0 (en) Process for decomposing soap by means of high-temperature treating
ATE173270T1 (de) Verfahren zur herstellung von 1-beta-d- arabinofuranosylcytosine
KR950011928B1 (ko) 사문석을 주제로한 흡착제 제조방법
ATE128327T1 (de) Verfahren zur herstellung von getrocknetem kollagen.
GB1027978A (en) Gelatine degradation produces and a process for producing them
SU1011643A1 (ru) Способ получени 1-метил-5-амино-4-нитроимидазола
DE68900524D1 (de) Verfahren zur herstellung von benzylmerkaptan.
ATA373478A (de) Plattenfoermiges bauelement sowie vorrichtung und verfahren zudessen herstellung
KR890001464A (ko) 제라틴을 이용한 건포류의 연질화 방법
GB2000146A (en) Stabilisation of nitrocellulose after pressure boiling

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties